Voyager Therapeutics (VYGR) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $55.5 million.
- Voyager Therapeutics' Shares Outstanding rose 172.38% to $55.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.5 million, marking a year-over-year increase of 172.38%. This contributed to the annual value of $54.7 million for FY2024, which is 2428.11% up from last year.
- Latest data reveals that Voyager Therapeutics reported Shares Outstanding of $55.5 million as of Q3 2025, which was up 172.38% from $55.4 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Shares Outstanding registered a high of $55.5 million during Q3 2025, and its lowest value of $37.6 million during Q1 2021.
- Over the past 5 years, Voyager Therapeutics' median Shares Outstanding value was $43.8 million (recorded in 2023), while the average stood at $45.5 million.
- As far as peak fluctuations go, Voyager Therapeutics' Shares Outstanding surged by 139.3% in 2021, and later soared by 2505.36% in 2024.
- Quarter analysis of 5 years shows Voyager Therapeutics' Shares Outstanding stood at $37.9 million in 2021, then increased by 1.83% to $38.6 million in 2022, then increased by 14.05% to $44.0 million in 2023, then rose by 24.28% to $54.7 million in 2024, then grew by 1.37% to $55.5 million in 2025.
- Its Shares Outstanding was $55.5 million in Q3 2025, compared to $55.4 million in Q2 2025 and $55.2 million in Q1 2025.